Background: Special attention has been paid to the sequelae caused by SARS-CoV 2 infection (Long-COVID). the prevalence of these sequelae in patients with rheumatological diseases has not been studied in detail. As these patients have immunosuppressive therapy and this syndrome has inflammatory characteristics. we postulate that these patients will have a lower prevalence of sequelae. https://www.diwalishare.com/product-category/navionics-cartography-5/